Answers are grounded in this paper and cite their sources.
The 3-aminoquinzolinediones represent a new series of antibacterial agents structurally related to the fluoroquinolones. They are inhibitors of bacterial gyrase and topoisomerase IV and demonstrate clinically useful antibacterial activity against fastidious Gram-negative and Gram-positive organisms, including multidrug- and fluoroquinolone-resistant organisms. These agents also demonstrate in vivo efficacy in murine systemic infection models.
No takes yet. Share an insight, caveat, or question.
Ellsworth et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: